PHOE:TASEPhoenix Financial Ltd Analysis
Data as of 2026-03-14 - not real-time
$15.30
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Phoenix Asia Holdings is trading around $15.30, which is dramatically above its DCF‑derived fair value of roughly $1.90 and carries a trailing P/E near 300× versus an industry average of about 30×, indicating severe overvaluation. Technical indicators are mixed: RSI sits at a neutral 48, the MACD histogram is modestly positive suggesting a slight bullish tilt, and the price is comfortably above the calculated support of $10.36 but well below the resistance near $22.66. Volume trends are weakening, and short interest is minimal at just 0.31% of float, implying limited immediate selling pressure.
Fundamentally, the company posts solid growth metrics with revenue up 29% YoY, strong gross (≈30%) and operating margins (≈15%), and an impressive ROE above 40%, supported by ample cash and negligible debt. However, the stock pays no dividend, exhibits extreme 30‑day volatility (over 900%) and an anomalous negative beta, and liquidity is deteriorating, all of which amplify risk. The combination of lofty valuation, decent earnings quality, and heightened market risk leads to a cautious outlook: short‑term hold, medium‑term sell, and a long‑term hold contingent on a price correction.
Fundamentally, the company posts solid growth metrics with revenue up 29% YoY, strong gross (≈30%) and operating margins (≈15%), and an impressive ROE above 40%, supported by ample cash and negligible debt. However, the stock pays no dividend, exhibits extreme 30‑day volatility (over 900%) and an anomalous negative beta, and liquidity is deteriorating, all of which amplify risk. The combination of lofty valuation, decent earnings quality, and heightened market risk leads to a cautious outlook: short‑term hold, medium‑term sell, and a long‑term hold contingent on a price correction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Neutral technical stance with modest bullish MACD signal
- Severe overvaluation relative to fundamentals
- Low short interest and decreasing volume
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Persistently high valuation multiples
- Extreme price volatility and negative beta
- Weakening liquidity and limited upside potential
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong earnings quality and growth trajectory
- Potential for price correction to align with intrinsic value
- Continued exposure to high market and liquidity risk
Key Metrics & Analysis
Financial Health
Revenue Growth29.30%
Profit Margin13.93%
P/E Ratio305.9
ROE42.60%
ROA17.88%
Debt/Equity0.81
P/B Ratio98.0
Op. Cash Flow$1.2M
Free Cash Flow$1.1M
Industry P/E29.1
Technical Analysis
TrendNeutral
RSI48.4
Support$10.36
Resistance$22.66
MA 20$15.47
MA 50$17.35
MA 200$12.73
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value$1.92
GradeOvervalued
TypeGrowth
Risk Assessment
Beta-4.48
Volatility938.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.